Clinical trialNCT03567382CompletedPhase 4Interventional

Arresting Vertical Transmission of Hepatitis B Virus

SponsorUniversity of North Carolina, Chapel HillEnrollment179Hepatitis BVertical Transmission of Infectious Disease

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this pilot study is to demonstrate the feasibility of adding HBV screening and treatment of pregnant women to the existing HIV PMTCT platform in order to prevent mother-to-child transmission of hepatitis B virus.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Peyton Thompson, MD
University of North Carolina, Chapel Hill
Principal Investigator
clinicaltrials.gov ↗
Steven Meshnick, MD
University of North Carolina, Chapel Hill
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Democratic Republic of the Congo

Kinshasa School of Public Health
Kinshasa, Democratic Republic of the Congo

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Monovalent HBV vaccineTenofovir disoproxil →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 24 Sept 2018
Primary completion: 6 Mar 2020
Completion: 15 Aug 2020
Last update posted: 24 Feb 2021
Registered enrollment: 179
Registry id: NCT03567382

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.